The North America Non-alcoholic Steatohepatitis Therapeutic & Diagnostic Market is witnessing steady growth due to the rising burden of metabolic disorders, increasing awareness of liver health, and expanding adoption of advanced diagnostic technologies. Continuous investments in targeted therapeutics, non-invasive liver assessment methods, and biomarker-based diagnostics are improving...